56826-69-8Relevant articles and documents
Efficient Pyrazolo[5,4-f]quinoxaline Functionalized Os(II) Based Emitter with an Electroluminescence Peak Maximum at 811 nm
Zhu, Ze-Lin,Wang, Sheng-Fu,Fu, Li-Wen,Tan, Ji-Hua,Cao, Chen,Yuan, Yi,Yiu, Shek-Man,Zhang, Ye-Xin,Chi, Yun,Lee, Chun-Sing
supporting information, (2021/12/09)
Upon fusing the pyrazinyl pyrazole entity in giving pyrazolo[3,4-f]quinoxaline chelate, the corresponding Os(II) based NIR emitter exhibited “invisible” and efficient electroluminescence with a peak maximum at 811 nm. A maximum external quantum efficiency
Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1
Catalano, John G.,Gudmundsson, Kristjan S.,Svolto, Angilique,Boggs, Sharon D.,Miller, John F.,Spaltenstein, Andrew,Thomson, Michael,Wheelan, Pat,Minick, Doug J.,Phelps, Dean P.,Jenkinson, Stephen
experimental part, p. 2186 - 2190 (2010/07/05)
Stereorandom and diastereoselective syntheses of a novel 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system are described. Derivatives of all four diastereomers were prepared and isolated in >98% ee. The pure enantiomers were compared in order t
QUINOLYNYLMETHYLIMIDIZOLES AS THERAPEUTIC AGENTS
-
Page/Page column 14; 15, (2008/12/07)
Disclosed herein is a compound of the formula (I):(I).Therapeutic methods, compositions and medicaments related thereto are also disclosed.